The trademark application NORTHERA was filed by H. Lundbeck A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on June 13, 2021, and it was registered by office on September 20, 2021 without any oppositions.
The application was filed in Danish (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals and medical preparations and substances
Vaccines
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system
Pharmaceutical preparations and substances acting on the central nervous system
Central nervous system stimulants
Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases
Pharmaceutical preparations and substances used for the prevention, management and treatment of headaches, migraines, pain, immune and inflammatory disorders and diseases, dementia, Alzheimer's disorder and disease, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease
Pharmaceutical preparations and substances used for the prevention, management and treatment of falls, movement disorders and diseases, dyskinesia
Pharmaceutical preparations for the prevention and treatment of neurogenic orthostatic hypotension (NOH), low blood pressure, dizziness, lightheadedness gait stiffness
Preparations, substances, reagents and agents for diagnostic and medical purposes.